Amyris News and Resources

Amyris, a synthetic biology and industrial biotechnology company, has secured a $12.3 million agreement through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-C) from the Administration for Strategic Preparedness and Response’s (ASPR) Center for Industrial Base Management and Supply Chain (IBMSC). The